Navigation Links
Rice bioengineers pioneer techniques for knee repair

A breakthrough self-assembly technique for growing replacement cartilage offers the first hope of replacing the entire articular surface of knees damaged by arthritis. The technique, developed at Rice University's Musculoskeletal Bioengineering Laboratory, is described in this month's issue of the journal Tissue Engineering.

"This has significant ramifications because we are now beginning to talk, for the first time, about the potential treatment of entire arthritic joints and not just small defects," said lead researcher and lab director Kyriacos Athanasiou, the Karl F. Hasselmann Professor of Bioengineering.

Athanasiou's new self-assembly method involves a break from conventional wisdom in bioengineering; almost all previous attempts to grow replacement transplant tissues involved the use of biodegradable implants that are seeded with donor cells and growth factors. These implants, which engineers refer to as scaffolds, foster the tissue growth process by acting as a template for new growth, but they always present a risk of toxicity due to the fact that they are made of materials that aren't naturally found in the body.

In the newly reported findings, Athanasiou and postdoctoral researcher Jerry Hu, using nothing but donor cells, grew dime-sized disks of cartilage with properties approaching those of native tissue. In a follow-up study due for publication soon, graduate student Christopher Revell refined the process to produce disks that are virtually identical to native tissue in terms of both mechanical and biochemical makeup.

In a third, and perhaps most impressive breakthrough, Athanasiou and Hu used the self-assembly approach to grow the entire articular surface of the distal femur. Each of these unbroken samples were tailored three-dimensionally to fit a specific rabbit femur.

"If you told me 10 years ago that we would be making entire articular end caps via self assembly I would have said you were crazy," said Athanas
'"/>

Source:Rice University


Page: 1 2

Related biology news :

1. Researchers pioneer new gene therapy technique using natural repair process
2. Diabetes researchers pioneer islet cell xenotransplantation in primate studies
3. Newer imaging techniques may lead to over-treatment
4. Evolutionary biology research techniques predict cancer
5. U of MN uses robotic surgery techniques in cardiac cell therapy research
6. Cloning techniques produce FDA-approved antibiotic
7. Imaging techniques permit scientists to follow a day -- or four -- in the life of a cell
8. Circulating stem cells play small role in lung repair
9. Discovering the first steps in transcription-coupled repair
10. Common enzyme is a key player in DNA repair
11. Dartmouth study finds that arsenic inhibits DNA repair

Post Your Comments:
(Date:11/9/2009)...ing Harbor, N.Y. Oncologists have had their hands...have mutations that disable a protein called p53. ...s several cancer-fighting operations within cells.... often cannot be treated. , These tumors might ...ew study from Cold Spring Harbor Laboratory (CSHL)...
(Date:11/9/2009)...illiance of butterfly wings has inspired a 3.2m, t...r innovation in the fields of security, energy and...ernational technology company QinetiQ have just si...ologies based on groundbreaking physical sciences ... physicists from the University of Exeter and Qine...
(Date:11/9/2009)...PHIA, NOVEMBER 9, 2009 A nutritionist whose rese...les to the federal Women, Infants and Children (WI...nes Higgins Award for outstanding achievement in t...arrison, Ph.D., MNS, , a professor in the Departme...of California, Los Angeles School of Public Health...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 1Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 2Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 3Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 4Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 5Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 6MWW Groups Washington D C Office Announces Two New Client Wins in Its Government Relations and Lobbying Practice 57057 1MWW Groups Washington D C Office Announces Two New Client Wins in Its Government Relations and Lobbying Practice 57057 2Vocollect and Boston Software Systems Announce Strategic Partnership 57054 1Vocollect and Boston Software Systems Announce Strategic Partnership 57054 2Vocollect and Boston Software Systems Announce Strategic Partnership 57054 3
...rominent scientific societies sponsored briefings ...anage natural areas after they have been impacted ...ociety of America (ESA), Council on Food, Agricult...nce Society of America (SSSA), the educational bri...ds of forest ecology, forest soil science and reso...
...t breed of supercomputers have hardware set up not...etworks of seemingly random data. And now, a multi...ed $4.0 million to develop software for these supe...webs of information can be found: from internet se...cal networks. , The difference between the new b...
...RELEASE , Detecting flu viruses in remote areas ...ociety , Researchers in Ohio and New Mexico are ...itive test to detect flu viruses one that require... of the world where new flu viruses often emerge. ... rather than antibodies, is in the July 2 issue of...
Other Biology News:Ecology, economics and soil societies brief Congress on post-wildfire resource management 2Multithreaded supercomputer seeks software for data-intensive computing 2Multithreaded supercomputer seeks software for data-intensive computing 3American Chemical Society's Weekly PressPac -- July 9, 2008 2American Chemical Society's Weekly PressPac -- July 9, 2008 3American Chemical Society's Weekly PressPac -- July 9, 2008 4American Chemical Society's Weekly PressPac -- July 9, 2008 5American Chemical Society's Weekly PressPac -- July 9, 2008 6American Chemical Society's Weekly PressPac -- July 9, 2008 7American Chemical Society's Weekly PressPac -- July 9, 2008 8American Chemical Society's Weekly PressPac -- July 9, 2008 9
(Date:11/6/2009)...irstCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP...Docherty, president and chief operating officer, w...nvestor Summit on November 10, 2009 at 4:00 PM at ...will provide an overview of the Company,s leading ...nterferon Alpha-2b. The slide show portion of the...
(Date:11/6/2009)...-FirstCall/ -- ,, 3Q09 Corporate Highlights:...arketing Authorization to Astellas Pharma Europe L...iness activities Expanded management team to incl...ctor, Commercial Operations Appointed Bradford S....chairman , Upcoming 2009 Milestones: ,...
(Date:11/6/2009)...-- Intarcia Therapeutics, Inc. delivered two prese...uous delivery of exenatide) program for the treatm...s Technology Meeting in San Francisco, CA: ,, (...1/SFTU126LOGO ) ,, Continuous Subcutaneous De...cose, HbA1c and Reduces Weight in a 28-day Phase 1...
(Date:11/5/2009)...-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today...rter ended September 30, 2009. GenVec reported a n...three months ended September 30, 2009 compared to ...e comparable quarter of 2008. For the nine months ...4.1 million ($0.15 per share), compared to a net l...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...versity,(SLU) recognized St. Louis-based Sigma-Ald...oring the life science and high technology company...onation, the third largest,in Sigma-Aldrich histor...equipment that will be used by the university,s me...newscom.com/cgi-bin/prnh/20071119/AQM157 ) "Sigma...
...peutics,Inc. (Nasdaq: CVTX ) announced today that...otified the Company that its supplemental new,drug... for Ranexa(R),(ranolazine extended- release table...iption Drug User Fee Act (PDUFA) action date for b... an expansion to the approved product labeling for...
...isk Inc.,announced today that it has signed an exc...t Prandin(R) (repaglinide). Under the terms of the...(R) and, upon approval by,the US Food and Drug Adm...DA for a repaglinide/metformin fixed dose combinat...ve a right of first refusal to obtain,marketing ri...
Other Biology Technology:Saint Louis University Honors Sigma-Aldrich Corp. for $1 Million Donation 2FDA Accepts Ranexa(R) sNDA and NDA for Filing 2FDA Accepts Ranexa(R) sNDA and NDA for Filing 3Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R) 2Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R) 3
Mouse Anti-Yersinia pestis Capsular F1 Antigen Monoclonal Antibody, Unconjugated, Clone YBF19 from QED Bioscience Inc.
Diethyl pyrocarbonate from Research Organics, Inc.
Cytofix Buffer from BD Biosciences Pharmingen
Cytofix/Cytoperm Kit from BD Biosciences Pharmingen
Biology Products: